XML 22 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Detail) - Summary Of Changes In SARs Outstanding (USD $)
9 Months Ended
Sep. 30, 2013
Weighted Average Remaining Contractual Term [Roll Forward]  
Granted 2 years 3 months 18 days
Stock appreciation rights (SARs)
 
SARs [Roll Forward]  
Outstanding at December 31, 2012 (in shares) 2,000,000
Granted (in shares) 400,000
Forfeited (in shares) 0
Exercised (in shares) (400,000)
Outstanding at September 30, 2013 (in shares) 2,000,000 [1],[2]
Vested and exercisable at September 30, 2013 (in shares) 1,000,000 [1]
Per Share Weighted- Average Exercise Price [Roll Forward]  
Outstanding at December 31, 2012 (in Dollars per share) $ 24.59
Granted (in Dollars per share) $ 49.37
Forfeited (in Dollars per share) $ 0.00
Exercised (in Dollars per share) $ 18.80
Outstanding at September 30, 2013 (in Dollars per share) $ 30.11 [1],[2]
Vested and exercisable at September 30, 2013 (in Dollars per share) $ 21.00 [1]
Per Share Weighted Average Grant Date Fair Value [Roll Forward]  
Outstanding at December 31, 2012 (in dollars per share) $ 9.04
Granted (in Dollars per share) $ 14.88
Forfeited (in Dollars per share) $ 0.00
Exercised (in Dollars per share) $ 7.02
Outstanding at September 30, 2013 (in Dollars per share) $ 10.46 [1],[2]
Vested and exercisable at September 30, 2013 (in Dollars per share) $ 7.98 [1]
Weighted Average Remaining Contractual Term [Roll Forward]  
Outstanding at December 31, 2012 4 years 36 days
Granted 6 years 4 months 13 days
Outstanding at September 30, 2013 4 years 2 months 5 days [1],[2]
Vested and exercisable at September 30, 2013 3 years 2 months 1 day [1]
[1] Total SARs outstanding had an intrinsic value of $59.3 million. SARs vested and exercisable had an intrinsic value of $39.8 million.
[2] As of September 30, 2013, 1.0 million of the SARs outstanding were unvested. The Company expects that substantially all of these unvested awards will vest in future periods.